Axpharma

What Axpharma does

AXpharma is a contract services business unit operating under Groupe ProductLife S.A., a privately held French public limited company founded in 2001 and headquartered in Paris. The company provides professional services across the full pharmaceutical and healthcare product lifecycle, serving biopharmaceutical firms, medical device and MedTech manufacturers, nutraceutical companies, and cosmetics/dermatological product companies. Its core offering is organized into five integrated pillars: Product Development (discovery through clinical), Market and Patient Access Services (policy, pricing, health economics, patient programs), Life Cycle Management (regulatory affairs, quality/compliance, and pharmacovigilance/safety vigilance), Strategy & Digital (consulting, transformation, IT), and Innovation (digital and medical innovation).

The company's service architecture is a platform-plus-modules model in which clients can engage individual service modules or bundle multiple pillars for end-to-end engagement. Its safety and vigilance (pharmacovigilance) capability is positioned as a core competency, alongside regulatory affairs and quality compliance functions that span drug, device, and consumer health products. No proprietary technology platforms, AI/ML systems, patents, or licensed software products are disclosed; the underlying technology stack is not publicly documented.

Commercially, AXpharma operates a direct enterprise sales motion, engaging global pharmaceutical and healthcare clients through professional services contracts. Pricing is not publicly disclosed. The company reaches prospects through content marketing, webinars, white papers, industry events, newsletters, and PR, and maintains an active website and careers portal. Headcount is stated at 1,001–5,000 employees, supporting a globally distributed delivery model, though no specific office locations, named customer logos, or revenue figures were disclosed in the source material.

Name

Axpharma

Legal name

Groupe ProductLife S.A.

Website

https://axpharma.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

AXpharma, a brand of Groupe ProductLife S.A., is a France-based global contract services firm delivering pharmacovigilance, regulatory affairs, product development, and market access solutions to biopharmaceutical, medical device, and consumer healthcare companies.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Healthcare Consulting Services

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Signal Detection & Safety Analytics (Epidemiology/RWE) (HLAGALAC)

akta.pro secondary industries

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF)

Keywords

• Pharmaceutical consulting services
• Pharmacovigilance services
• Regulatory affairs services
• Clinical development support
• Medical device consulting

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels4 records

Core offering

Axpharma is a contract services company providing end-to-end pharmaceutical and healthcare consulting across five pillars: Product Development, Market and Patient Access Services, Life Cycle Management (including pharmacovigilance and safety vigilance), Strategy and Digital, and Innovation. Services span biopharmaceutical drug development, medical device and MedTech support, consumer healthcare (nutraceuticals, cosmetics, dermatological solutions), regulatory affairs, quality and compliance, pricing and HTA, health economics, and digital transformation for life sciences clients.

Product overview

Axpharma, part of Product Life Group, offers a comprehensive portfolio of five integrated service pillars: Product Development (biopharmaceuticals, medical devices, nutraceuticals, cosmetics), Market and Patient Access Services (policy, pricing, health economics, patient programs), Life Cycle Management (regulatory affairs, quality, safety), Strategy & Digital (consulting, transformation, IT), and Innovation (digital and medical innovation). This is a platform-plus-modules architecture where clients can engage individual service modules or leverage multiple pillars for integrated pharmaceutical and healthcare development solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Product Development

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Syneos Health: Global biopharmaceutical services organization with clinical, regulatory, safety, and commercial capabilities — a comparable end-to-end peer serving overlapping biopharma customers.
• Medpace: Mid-sized global CRO providing clinical development and regulatory services to biopharma and MedTech — a comparable scaled peer in the same outsourced services market.
• PharmaLex: Specialized provider of regulatory affairs, pharmacovigilance, quality, and compliance consulting to life sciences companies — a focused direct peer to Axpharma's core lifecycle and safety offerings.
• Parexel International: Private global CRO and biopharmaceutical services firm covering clinical development, regulatory, pharmacovigilance, and market access — a closely comparable mid-to-large peer to Axpharma's service portfolio.
• ICON plc: Global CRO offering comprehensive clinical, pharmacovigilance, regulatory, and post-marketing safety services to biopharma and medical device clients — directly comparable in service scope and customer base to Axpharma.
• ProPharma Group: Life sciences consulting firm providing regulatory compliance, pharmacovigilance, and quality services to pharma, biotech, and medical device companies — a direct peer in Axpharma's core regulatory/PV niche.

Broad incumbents

• Charles River Laboratories: Large life sciences services provider with safety assessment, regulatory, and discovery/preclinical capabilities — a broader incumbent with overlapping safety and lifecycle service lines.
• IQVIA: Largest global life sciences services provider with overlapping capabilities in regulatory affairs, safety/pharmacovigilance, HEOR, market access, and consulting — a much broader incumbent in the same end markets as Axpharma.
• Labcorp Drug Development (Fortrea): Post-spin CRO covering clinical, central lab, regulatory, and pharmacovigilance services for biopharma — a broader incumbent with overlapping service pillars.

Emerging players

• Inotiv: Contract research organization providing preclinical, safety, and regulatory support services to pharma and medical device companies — an emerging peer with partial overlap in safety and lifecycle services.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axpharma